Daiichi Sankyo Germany seeks to support cancer care in a collaboration with Prosoma by increasing awareness of their digital app ‘Living Well’ which aims to provide a comprehensive programme supporting the mental health of people recently diagnosed with cancer or undergoing treatment
Munich– (November 2nd, 2022) – Daiichi Sankyo Germany has taken a vital step towards attempting to improve patient care through a recent partnership with Prosoma, a digital therapeutics company specialising in oncology. The partnership intends to promote the use of Prosoma’s digital health app called ‘Living Well’ by reaching out to and generating awareness among the oncology community. ‘Living Well’ is a CE-certified application designed to improve patients’ quality of life and reduce symptoms of stress, anxiety and depression associated with cancer diagnosis and treatment at various stages of cancer.1 The certification ensures adherence with highest European standards.
“Doing more for patients by expanding our partnerships with providers of support services that can help make a difference in patients’ lives is of the utmost importance for us”, said Dr. Martina Witzel, Head of Oncology Germany. “We believe that there is still a high unmet need for mental health support services and that Prosoma is the right partner to help reduce the mental burden for patients.” In order to promote the ‘Living Well’ app best, the Daiichi Sankyo Germany will generate awareness among the oncology community digitally, at national conferences, distribution of flyers at face-to-face visits of physicians and many more. Piotr Grudzinski, co-founder and CEO of Prosoma GmbH, said: “We’re very appreciative of the support we have received from Daiichi Sankyo Germany. This partnership is incredibly valuable for us and we are happy that this collaboration may help to reach many more patients and aims to alleviate their cancer burden.”
The German insurer Techniker Krankenkasse is the first to reimburse the app as part of their mental health offering, demonstrating that digital health services are getting traction by payors as an important to improve patient outcomes. “Digital health services are becoming ever more significant. We recognize the value of mental health apps such as Prosoma’s “Living Well,” said Thomas Heilmann, Head “Versorgungsmanagement Angebote” at Techniker Krankenkasse.
About Daiichi Sankyo
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichi-sankyo.eu.
As a global leader in Digital Therapeutics for oncology, We provide patients with comprehensive solutions that are fully tailored to their medical conditions. Prosoma created a portfolio of medical software products by combining expertise in medicine and technology and covering cancer patients’ entire behavioral support needs. To learn more about us, visit www.prosoma.com or connect through LinkedIn.
About ‘Living Well’
Living Well is an application designed to improve the quality of life and reduce stress, anxiety, and depression symptoms related to cancer diagnosis and treatment. It helps patients, and caregivers of cancer patients deal with their emotions and stress, build healthy habits and support them through the recovery process. The application can be used as a tool complementing treatment or as a sole intervention. The Living Well App is already reimbursed by healthcare insurance companies in Germany, and Prosoma is also aiming to have the costs of its products covered by healthcare systems in the US, the UK, and Poland. For more information, please visit www.prosoma.com/en/living-well.
Daiichi Sankyo Deutschland GmbH:
Anke von Zabern
81379 Munich • Germany
+49 89 7808 368 (office)
+49 172 8380303 (mobile)
Head of Marketing
10707 Berlin • Germany
+49 305 2015188 (office)
Germany differentiates lifestyle applications from medical applications by calling them DiGA, which is an abbreviation for Digitale Gesundheitsanwendungen,